Cardlytics vs System1
CDLX and SST side by side, both in computer programming, data processing, and other computer related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CDLX and SST compare
System1 is the larger company, worth 1.8 times as much as Cardlytics ($17.8M against $9.7M).
Cardlytics grew revenue faster over the last twelve months (−25.3% versus −42.9% for System1).
Cardlytics keeps more of each dollar of sales as profit, with a net margin of −20.8% compared with −50.7% at System1.
Cardlytics scores higher on the StockData Score (7 against 2 for System1), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CDLX | SST |
|---|---|---|
| Size and price | ||
| Market cap | $9.7M | $17.8M |
| Share price | $1.65 | $1.70 |
| Change, 1 year | −88.5% | −61.5% |
| Change, 5 years | −99.8% | −98.3% |
| Beta (5Y) | 2.50 | 0.72 |
| Employees | 275 | 250 |
| StockData Score | ||
| Total score | 7 (better) | 2 |
| Valuation score | 1 | 1 |
| Growth score | 0 | 1 (better) |
| Performance score | 1 (better) | 0 |
| Health score | 5 (better) | 0 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.1× (better) | 0.1× |
| FCF yield | −74.1% | – |
| Growth | ||
| Revenue growth (TTM) | −25.3% (better) | −42.9% |
| Revenue growth, 5Y average | 4.5% | – |
| Profitability | ||
| Gross margin | – | 50.7% |
| Operating margin | −19.2% (better) | −51.0% |
| Net margin | −20.8% (better) | −50.7% |
| FCF margin | −4.1% | – |
| Return on equity | – | −582% |
| Return on invested capital | – | −30.2% |
| Financial health | ||
| Interest coverage | – | −3.4× |
| Current ratio | 1.82 (better) | 0.77 |
| Altman Z-score | −8.24 | −4.87 (better) |
| Piotroski F-score | 6 (better) | 3 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 29.6% | 5.7% |
| Insider net buying, 12 months | −$406K | $80.7K (better) |
Go deeper
- CDLX stock overview
- CDLX income statement
- CDLX valuation and score
- SST stock overview
- SST income statement
- SST valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.